Shriners Hospitals for Children, Philadelphia, PA 19140, USA.
Spine (Phila Pa 1976). 2010 Aug 1;35(17):1648-54. doi: 10.1097/BRS.0b013e3181ce8f4b.
Retrospective review of the literature.
To review the current literature as well as recent trends in bone grafting techniques available for children.
The currently accepted gold standard in bone grafting for adolescent idiopathic scoliosis (AIS) is autogenous iliac crest. Due to questions concerning complications such as donor site pain, other options have been explored, including various allograft sources, demineralized bone matrix, and bone morphogenetic protein.
A review of the current medical literature was completed and additional case examples are presented.
A review of the literature reveals that up to 31% of patients have persistent pain at 2 years post surgery when autogenous iliac crest bone graft is harvested. Allograft supplementation of local autograft has been demonstrated in the literature to be as effective as autogenous iliac crest bone grafting in contributing to a successful posterior spinal fusion in patients with AIS. Modern demineralized bone matrix formulations have been found in both animal models as well as in a recent retrospective clinical review to contribute to a successful posterior spinal fusion in AIS. Bone morphogenetic protein has been shown to contribute to a successful posterior spinal fusion in complex pediatric spinal deformity patients. At 2 years follow-up, patients who underwent a posterior instrumented spinal fusion that was not augmented with any bone graft appear to have successful spinal fusions.
Although autogenous iliac bone graft remains the benchmark to which bone grafting materials are compared, other options including the placement of no bone graft at all provides similar fusion rates in patients with AIS.
文献回顾。
回顾目前可用于儿童的骨移植技术的文献以及最新趋势。
目前青少年特发性脊柱侧凸(AIS)骨移植的金标准是自体髂嵴。由于对诸如供体部位疼痛等并发症的质疑,已经探索了其他选择,包括各种同种异体移植物来源、脱钙骨基质和骨形态发生蛋白。
完成了对当前医学文献的回顾,并提出了其他案例。
文献回顾表明,当自体髂嵴骨移植时,多达 31%的患者在手术后 2 年仍有持续性疼痛。文献中已经证明同种异体移植物补充局部自体移植物与自体髂嵴骨移植一样有效,可促进 AIS 患者的后路脊柱融合成功。在动物模型和最近的回顾性临床研究中都发现了现代脱钙骨基质制剂,有助于 AIS 患者的后路脊柱融合成功。骨形态发生蛋白已被证明可促进复杂儿科脊柱畸形患者的后路脊柱融合成功。在 2 年的随访中,未接受任何骨移植增强的后路器械性脊柱融合的患者似乎有成功的脊柱融合。
尽管自体髂骨仍然是骨移植材料比较的基准,但其他选择,包括根本不放置骨移植,在 AIS 患者中提供了相似的融合率。